The value of prostate MRI with endorectal coil in detecting seminal vesicle involvement in patients with prostate cancer - Abstract

BACKGROUND: In prostate cancer, detection of seminal vesicle involvement is important because it influences the treatment planning and prognosis of the patients.

OBJECTIVES: The objective of this study was to determine the value of prostate MRI with endorectal coil in the detection of seminal vesicle involvement in patients with prostate cancer.

PATIENTS AND METHODS: A total number of 238 biopsy-proven prostate cancer patients were examined by 1.5 Tesla MRI with a combination of pelvic and endorectal coils to detect seminal vesicle involvement. After radical prostatectomy, the MRI results were compared with pathology results.

RESULTS: Seminal vesicle involvement was detected in 67 (28.1%) patients. Pathology confirmed the involvement of seminal vesicles by prostate cancer in 63 patients. In two patients, seminal vesicle involvement was diagnosed by pathology but not detected by MRI. The sensitivity was 0.97 [95% confidence interval = 0.89-0.99], the specificity was 0.98 [95% confidence interval = 0.94-0.99], the positive predictive value was 0.94 [95% confidence interval = 0.85-0.98], and the negative predictive value was 0.99 [95% confidence interval = 0.96-0.99].

CONCLUSIONS: MRI with endorectal coil is a valuable imaging technique with suitable accuracy in detecting seminal vesicle involvement in prostate cancer.

Written by:
Ghafoori M, Alavi M, Shakiba M, Hoseini K.   Are you the author?
Department of Radiology, Hazrat Rasoul Akram Hospital, School of Medicine, Iran; University of Medical Sciences, Tehran, Iran; Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences, Tehran, Iran; Deputy of Research and Technology, Ministry of Health and Medical Education, Tehran, Iran; Department of Urology, School of Medicine, Hazrat Rasoul Akram Hospital, Iran University of Medical Sciences, Tehran, Iran.

Reference: Iran J Radiol. 2015 Jan 17;12(1):e14556.
doi: 10.5812/iranjradiol.14556


PubMed Abstract
PMID: 25793086

UroToday.com Prostate Cancer Section